{"id":1661,"date":"2025-11-27T13:07:32","date_gmt":"2025-11-27T13:07:32","guid":{"rendered":"https:\/\/admarebio.com\/news-events\/news-insights\/"},"modified":"2026-06-26T17:19:08","modified_gmt":"2026-06-26T17:19:08","slug":"castl-expands-national-biomanufacturing-training-with-bioinnovation-scientist-bis-program","status":"publish","type":"post","link":"https:\/\/admarebio.com\/news-events\/news-insights\/castl-expands-national-biomanufacturing-training-with-bioinnovation-scientist-bis-program\/","title":{"rendered":"CASTL Expands National Biomanufacturing Training with BioInnovation Scientist (BIS) Program"},"content":{"rendered":"\n

Charlottetown, PE \u2013 November 24, 2025 \u2013<\/strong> The Canadian Alliance for Skills and Training in Life Sciences (CASTL)<\/strong> is proud to announce that it has officially assumed delivery of the BioInnovation Scientist (BIS) Programs: Foundations and Industry Essentials<\/strong>, originally developed and offered by adMare BioInnovations to prepare both early-career scientists and non-scientists for impactful careers in the country\u2019s rapidly expanding life sciences and biomanufacturing sectors. As part of this expanded offering, CASTL is introducing an optional add-on to the BIS Foundations program, giving learners the opportunity to enhance their training with practical, hands-on technical experience that strengthens their overall industry readiness.<\/p>\n\n\n\n


Designed to strengthen Canada\u2019s life sciences workforce, the BIS Foundations and BIS Industry Essentials programs provide a practical understanding of the drug discovery and development process, including the commercial realities and challenges of bringing new therapeutics to market. The training empowers early-career professionals with the foundational knowledge, applied insight, and professional network needed to succeed in the country\u2019s rapidly evolving life sciences ecosystem.<\/p>\n\n\n\n

\u201cThese programs have already made a measurable impact, supporting more than 270 learners across Canada in building the skills and confidence to pursue careers in drug development,\u201d said CASTL CEO Penny Walsh-McGuire. \u201cWe\u2019re thrilled to expand access to these courses by offering an optional hands-on technical training component and to continue supporting the next generation of innovators driving Canada\u2019s biomanufacturing sector forward.\u201d<\/p>\n\n\n\n


\u201cAt adMare, our priority is building globally competitive Canadian life sciences companies, including developing the leadership they need to succeed,\u201d said Gordon C. McCauley, President and CEO adMare BioInnovations. \u201cTransitioning the BIS programs to CASTL allows us to focus on that mission while ensuring these early-career training streams continue to grow. Combined with CASTL\u2019s specialized biomanufacturing training expertise and dedicated training infrastructure, these programs will continue to build the foundational commercialization skills to help turn break-through discoveries into life-changing impact.\u201d<\/p>\n\n\n\n


About the Programs<\/strong><\/h3>\n\n\n\n


BIS Foundations<\/strong><\/p>\n\n\n\n

This 8-week virtual program (4\u20138 hours per week) is designed for individuals with a science background seeking R&D roles in life sciences. Participants gain insight into the full therapeutic development process\u2014from discovery to commercialization\u2014through guided modules, expert-led webinars, and interactive peer discussions.<\/p>\n\n\n\n